Fairpointe Capital LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 169 filers reported holding HAEMONETICS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Fairpointe Capital LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2017$2,358,000
-18.8%
59,700
-16.6%
0.05%
-17.5%
Q1 2017$2,905,000
+0.9%
71,6000.0%0.06%
-1.7%
Q4 2016$2,878,000
+3.7%
71,600
-6.5%
0.06%
-6.5%
Q3 2016$2,774,000
+24.9%
76,6000.0%0.06%
+24.0%
Q2 2016$2,221,000
+0.6%
76,600
+21.4%
0.05%
+8.7%
Q1 2016$2,207,000
+8.5%
63,1000.0%0.05%
+24.3%
Q4 2015$2,034,000
+11.0%
63,100
+11.3%
0.04%
+19.4%
Q3 2015$1,833,000
+11.1%
56,700
+42.1%
0.03%
+34.8%
Q2 2015$1,650,000
-7.9%
39,9000.0%0.02%
-4.2%
Q1 2015$1,792,000
-21.1%
39,900
-34.3%
0.02%
-20.0%
Q4 2014$2,271,000
+7.1%
60,7000.0%0.03%
+7.1%
Q3 2014$2,120,00060,7000.03%
Other shareholders
HAEMONETICS CORP shareholders Q1 2016
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders